Archive

Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina

Posted on January 30, 2019
in
by

NASDAQ, TSX: NVCN Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 30, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies and in the development...

Read More

Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences

Posted on January 22, 2019
in
by

NASDAQ, TSX: NVCN VANCOUVER, Jan. 22, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX:NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina,...

Read More

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Posted on January 14, 2019
in
by

NASDAQ, TSX: NVCN VANCOUVER, Jan. 14, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:NVCN) announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with...

Read More

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Posted on January 4, 2019
in
by

NASDAQ, TSX: NVCN VANCOUVER, Jan. 3, 2019 /CNW/ - ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum market value...

Read More

Neovasc Receives ISO 13485: 2016 Certification

Posted on December 21, 2018
in
by

NASDAQ, TSX: NVCN VANCOUVER, Dec. 21, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today...

Read More